High dose rate brachytherapy as monotherapy for localised prostate cancer: a hypofractionated two-implant approach in 351 consecutive patients

BACKGROUND: To report the clinical outcome of high dose rate brachytherapy as sole treatment for clinically localised prostate cancer. METHODS: Between March 2004 and January 2008, a total of 351 consecutive patients with clinically localised prostate cancer were treated with transrectal ultrasound...

Descripción completa

Detalles Bibliográficos
Autores principales: Tselis, Nikolaos, Tunn, Ulf W, Chatzikonstantinou, Georgios, Milickovic, Natasa, Baltas, Dimos, Ratka, Markus, Zamboglou, Nikolaos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671130/
https://www.ncbi.nlm.nih.gov/pubmed/23656899
http://dx.doi.org/10.1186/1748-717X-8-115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671130/
https://www.ncbi.nlm.nih.gov/pubmed/23656899
http://dx.doi.org/10.1186/1748-717X-8-115

Ejemplares similares